Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Automatic implantable cardioverter defibrillator: cost effectiveness

R N Hauer1, E F Wever, H J Crijns

  • 1Department of Cardiology, Heart-Lung Institute, University Hospital, Utrecht, The Netherlands.

Pacing and Clinical Electrophysiology : PACE
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arterial hypertension in patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme pilot survey on atrial fibrillation.

International journal of cardiology·2018
Same author

Clinical characterisation and risk stratification of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy ≥50 years of age.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2016
Same author

CC chemokine ligands in patients presenting with stable chest pain: association with atherosclerosis and future cardiovascular events.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2016
Same author

Identifying delayed left ventricular lateral wall activation in patients with non-specific intraventricular conduction delay using coronary venous electroanatomical mapping.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015
Same author

Right ventricular function in dilated cardiomyopathy and ischemic heart disease: assessment with non-invasive imaging.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015
Same author

Molecular genetic analysis of six Dutch families with atrial fibrillation.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015

Early defibrillator implantation may be cost-effective for cardiac arrest survivors. This study prospectively compares early automatic implantable cardioverter defibrillator (AICD) implantation versus conventional therapy in post-infarct patients.

Area of Science:

  • Cardiology
  • Medical Economics

Background:

  • Out-of-hospital cardiac arrest, often ventricular fibrillation, necessitates treatment strategies.
  • Conventional therapy involves drugs, then non-pharmacological methods like ablation or defibrillator implantation, which is lengthy and costly.
  • Early defibrillator implantation could be cost-effective, particularly when drug treatment success is low.

Purpose of the Study:

  • To conduct a prospective cost-effectiveness analysis of early automatic implantable cardioverter defibrillator (AICD) implantation.
  • To compare early AICD implantation with conventional therapy in successfully resuscitated post-infarct patients.

Main Methods:

  • A randomized trial comparing early AICD implantation versus conventional treatment.
  • Evaluation includes medical, economic, and quality-of-life aspects.

Related Experiment Videos

  • Study initiated in 1989, aiming for 60 patients, with 46 enrolled by June 1992.
  • Main Results:

    • Data collection ongoing, with results expected in 1993.
    • Cost-effectiveness ratios will be calculated for both study arms.

    Conclusions:

    • Prospective data on early AICD implantation cost-effectiveness is needed.
    • This study aims to provide crucial insights into optimizing cardiac arrest survivor treatment strategies.